Quotes 5-day view Delayed Nasdaq
01/11/2021
01/12/2021
01/13/2021
01/14/2021
01/15/2021
Date
34.76(c)
35.72(c)
34.52(c)
36.76(c)
35.85(c)
Last
94 642
98 626
166 224
353 928
184 789
Volume
-3.58% +2.76% -3.36% +6.49% -2.48% Change
Sales 2020
35,4 M - -
Net income 2020
-25,7 M - -
Net cash position 2020
211 M - -
P/E ratio 2020
-45,2x
Yield 2020
-
Sales 2021
66,3 M - -
Net income 2021
-1,23 M - -
Net cash position 2021
176 M - -
P/E ratio 2021
-844x
Yield 2021
-
Capitalization
1 209 M 1 209 M -
EV / Sales 2020
28,2x
EV / Sales 2021
15,6x
Nbr of Employees
45
Free-Float
77,9%
Frequency Therapeutics Inc. is a United States-based clinical-stage progenitor cell activation (PCA) regeneration company. The Company is focused on developing small molecule drugs that activate progenitor cells within the body to restore healthy tissue. It uses its PCA technology to develop a pipeline of progenitor cell activators. It focuses on various therapeutic areas, such as hearing loss, skin disorders,...
Notations Surperformance© of Frequency Therapeutics, Inc.
Trading Rating : Investor Rating :
All news about FREQUENCY THERAPEUTICS, INC.
News in other languages on FREQUENCY THERAPEUTICS, INC.
- No features available -
Analyst Recommendations on FREQUENCY THERAPEUTICS, INC.
Chart FREQUENCY THERAPEUTICS, INC.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends FREQUENCY THERAPEUTICS, INC.
Short Term Mid-Term Long Term Trends Neutral Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
5
Average target price
47,00 $
Last Close Price
35,85 $
Spread / Highest target
120%
Spread / Average Target
31,1%
Spread / Lowest Target
-24,7%
Please enable JavaScript in your browser's settings to use dynamic charts.
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
